Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Dec 15:865:172747.
doi: 10.1016/j.ejphar.2019.172747. Epub 2019 Oct 18.

Selected nucleos(t)ide-based prescribed drugs and their multi-target activity

Affiliations
Review

Selected nucleos(t)ide-based prescribed drugs and their multi-target activity

Gabriela Pastuch-Gawołek et al. Eur J Pharmacol. .

Abstract

Nucleos(t)ide analogues play pivotal roles as antiviral, cytotoxic or immunosuppressive agents. Here, we review recent reports of nucleoside analogues that exhibit broad-spectrum activity towards multiple life-threatening RNA and DNA viruses. We also present a discussion about nucleoside antimetabolites-approved antineoplastic agents-that have recently been shown to have antiviral and/or antibacterial activity. The approved drugs and drug combinations, as well as recently identified candidates for investigation and/or experimentation, are discussed. Several examples of repurposed drugs that have already been approved for use are presented. This strategy can be crucial for the first-line treatment of acute infections or coinfections and for the management of drug-resistant strains.

Keywords: Antineoplastic agents; Antiviral therapy; Chain termination; Nucleosides; Nucleotides; Prodrugs.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Structures of nucleos(t)ide-based drugs for the treatment of HBV infections.
Fig. 2
Fig. 2
Structures of nucleos(t)ide-based and non-nucleoside drugs used in combination with tenofovir and lamivudine for the treatment of HIV infections. Abbreviations: NRTIs - nucleoside reverse transcriptase inhibitors, NNRTIs - non-nucleoside reverse transcriptase inhibitors.
Fig. 3
Fig. 3
Sofosbuvir alone and in combination with other drugs in the treatment of HCV infections.
Scheme 1
Scheme 1
Mechanism of action of nucleoside-type drugs and prodrugs against herpesviruses. Abbreviations: ACV – acyclovir, BVDU – brivudine, IDU – idoxuridine, FCV – famciclovir, GCV – ganciclovir, PCV - penciclovir, TFT - trifluridine, VACV - valaciclovir, VDR – vidarabine, and VGCV – valganciclovir.
Fig. 4
Fig. 4
Nucleoside-based marketed drugs against various herpesviruses.
Fig. 5
Fig. 5
Additional nucleos(t)ide-based antiviral agents against various herpesviruses.
Fig. 6
Fig. 6
Structures of the nucleoside antimetabolites with potential antiviral activity.

References

    1. Abele G., Cox S., Bergman S., Lindborg B., Vissgarden A., Karlstrom A., Harmenberg J., Wahren B. Antiviral activity against VZV and HSV type 1 and type 2 of the (+) and (-) enantiomers of (R,S)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine, in comparison to other closely related acyclic nucleosides. Antivir. Chem. Chemother. 1991;2:163–169. doi: 10.1177/095632029100200306. - DOI
    1. Agrawal K., Das V., Vyas P., Hajdúch M. Nucleosidic DNA demethylating epigenetic drugs – a comprehensive review from discovery to clinic. Pharmacol. Ther. 2018;188:45–79. doi: 10.1016/j.pharmthera.2018.02.006. - DOI - PubMed
    1. Alexeeva I., Dyachenko N., Nosach L., Zhovnovataya V., Rybalko S., Lozitskaya R., Fedchuk A., Lozitsky V., Gridina T., Shalamay A., Palchikovskaja L., Povnitsa O. 6-Azacytidine – compound with wide spectrum of antiviral activity. Nucleosides Nucleotides Nucleic Acids. 2001;20:1147–1152. doi: 10.1081/NCN-100002508. - DOI - PubMed
    1. Alexeeva I., Nosach L., Palchykovska L., Usenko L., Povnitsa O. Synthesis and comparative study of anti-adenoviral activity of 6-azacytidine and its analogues. Nucleosides Nucleotides Nucleic Acids. 2015;34:565–578. doi: 10.1080/15257770.2015.1034363. - DOI - PubMed
    1. Andrei G., Sienaert R., McGuigan C., De Clercq E., Baizarini J., Snoeck R. Susceptibilities of several clinical varicella-zoster virus (VZV) isolates and drug-resistant VZV strains to bicyclic furano pyrimidine nucleosides. Antimicrob. Agents Chemother. 2005;49:1081–1086. doi: 10.1128/AAC.49.3.1081-1086.2005. - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources